Showing 3611-3620 of 6035 results for "".
- CooperVision Expands Leadership Teamhttps://modernod.com/news/coopervision-expands-leadership-team/2479259/CooperVision announced the hiring of Kamela Bearlin as Senior Global Brand Director, 1 Day Brands; and Jennifer Lambert as Senior Global Brand Director, Myopia Management; and promoted Elizabeth Lumb, BSc(Hons) MCOptom, FBCLA, to Director of Global Professional Affairs, Myopia Management.
- AcuFocus Appoints Industry Leader John Garland as Global Vice President of Saleshttps://modernod.com/news/acufocus-appoints-industry-leader-john-garland-as-global-vice-president-of-sales/2479257/AcuFocus announced that it has appointed John Garland as its Global Vice President of Sales. In his new role, he will be responsible for global sales strategy and will focus initially on building the US sales field team. Mr. Garland brings more than 30 years of experience to the position w
- Arctic Vision Announces Exclusive Licensing Agreement With ActualEyeshttps://modernod.com/news/arctic-vision-announces-exclusive-licensing-agreement-with-actualeyes/2479210/Arctic Vision and ActualEyes, a clinical stage Japanese biotech company committed to the research and development of cell therapy for corneal endothelial diseases, jointly announced an exclusive licensing agreement for Arctic Vision to develop and commercialize ActualEyes’ lead product cand
- Innovega’s eMacula System Shows Potential to Increase Independence for Visually Impairedhttps://modernod.com/news/innovegas-emacula-system-shows-potential-to-increase-independence-for-visually-impaired/2479190/The use of Innovega eMacula system, which pairs smart contact lenses with display eyewear, demonstrated positive results with partially sighted subjects for their daily tasks, including reading, smart phone use, and distance vision, according to research conducted at The Ohio
- Johnson & Johnson Vision Announces FDA Approval Of Tecnis Synergy And Tecnis Synergy Toric II IOLs In the UShttps://modernod.com/news/johnson-johnson-vision-announces-the-approval-of-tecnis-synergy-and-tecnis-synergy-toric-ii-iols-in-the-us/2479178/Johnson & Johnson Vision announced the FDA approval of Tecnis Synergy and Tecnis Synergy Toric II IOLs, and the Health Canada approval of Tecnis Synergy Toric II IOLs. This next-generation PCIOL is built on the legacy Tecnis platform and delivers a wide range of continuous vision with
- Ceyeber Announces Advisory Board of World-Renowned Ophthalmologistshttps://modernod.com/news/ceyeber-announces-advisory-board-of-world-renowned-ophthalmologists/2479167/Ceyeber, the developer of implantable intraocular lens technology designed for medical applications and augmented reality, has created a Medical Advisory Board consisting of top ophthalmologists. Ceyeber’s founder and CEO, Robert E. Grant, said, “
- New Contact Lens Update Focuses on Ocular Allergyhttps://modernod.com/news/new-contact-lens-update-focuses-on-ocular-allergy/2479141/The Centre for Ocular Research & Education (CORE) has published issue number 59 of its free online education magazine,
- Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.https://modernod.com/news/alcon-launches-systane-hydration-multi-dose-preservative-free-lubricant-eye-drops-in-the-u-s/2479131/Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of the newest addition to its innovative portfolio of dry eye products – Systane® Hydration Multi-Dose Preservative-Free (MDPF) Lubricant Eye Dro
- Market Scope: Backlog of 6 Million Cataract Surgeries Will Help Drive IOL Market Through 2026https://modernod.com/news/backlog-of-6-million-cataract-surgeries-will-help-drive-iol-market-through-2026/2479127/Pandemic-impacted 2020 led to a backlog of more than 6 million cataract surgeries globally, as procedures declined 25 percent to 22 million, the lowest number since 2010, mainly due to COVID-related shutdowns in elective surgeries, according to a Market Scope report. The amount of time it
- Orasis Pharmaceuticals Appoints Industry Veteran Paul Smith as President and Chief Operating Officerhttps://modernod.com/news/orasis-pharmaceuticals-appoints-industry-veteran-paul-smith-as-president-and-chief-operating-officer/2479112/Orasis Pharmaceuticals announced the appointment of Paul Smith as president and chief operating officer (COO). Mr. Smith brings over two decades of leadership in eye care. “I am excited to join Orasis Pharmaceuticals at such a pivotal time in the company’s h